Volume 17, Number 7—July 2011
Dispatch
Visceral Larva Migrans in Immigrants from Latin America
Maria-Carmen Turrientes, Ana Pérez de Ayala, Francesca F. Norman, Miriam Navarro, José-Antonio Pérez-Molina, Mercedes Rodriquez-Ferrer, Teresa Gárate, and Rogelio López-Vélez
Table
Descriptions of 4 cases of visceral larva migrans in immigrants from Latin America, Spain, April 1989–June 2008*
| Case no. |
Age, y/sex |
Origin |
Clinical signs and symptoms |
Chest radiograph results |
Eosinophil count,
absolute/mm3 (%) |
6-mo follow-up |
||
|---|---|---|---|---|---|---|---|---|
| Eosinophil count/mm3 |
Decrease in antibody titers |
Symptoms |
||||||
| 1 | 28/M | Bolivia | Asthma-like syndrome† | Slight right parahiliar infiltrate | 700 (17.0) | 500 | Yes | None |
| 2 | 29/F | Dominican Republic | Dry cough, dyspnea, chest pain, eosinophilic pneumonia | Bilateral alveolar infiltrates | 1,400 (10.5) | 600 | Yes | None |
| 3 | 5/F | Ecuador | Asthma-like syndrome, abdominal pain | No findings | 1,050 (15.0) | 700 | Yes | None |
| 4 | 40/F | Colombia | Abdominal pain | Not done | 1,500 (14.8) | 400 | Yes | Clinical improvement |
*All patients were treated with albendazole (10–15 mg/kg/d in 2 doses orally for 5 days).
†Wheezing and dry cough.
Page created: August 15, 2011
Page updated: August 15, 2011
Page reviewed: August 15, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.